SAGE

SAGE NASDAQ
178.54
-4.11
-2.25%
交易中 14:02 06/24 EDT
开盘
182.43
昨收
182.65
最高
184.35
最低
176.27
成交量
15.48万
成交均量(3M)
44.12万
52周最高
185.61
52周最低
79.88
换手率
0.30%
市值
91.32亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供SAGE SAGE股票价格,SAGE股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

SAGE Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. The Company's lead product candidate, SAGE-547 is an intravenous formulation of allopregnanolone, a neurosteroid that acts as a synaptic and extrasynaptic modulator of the Gamma-Amino Butyric Acid-A (GABAA) receptor. The Company's next-generation product candidates, SAGE-217 and SAGE-689, also target the GABAA receptor system. The Company is focused on developing drugs based on selective allosteric modulation of CNS synaptic and extrasynaptic receptors. The Company's chemistry platform is focused on the chemical scaffolds of endogenous or chemically modified synthetic neuroactive steroid compounds that are allosteric modulators of GABAA or N-Methyl-D-aspartic acid or N-Methyl-D-aspartate (NMDA) receptors.
展开 >

最近浏览

名称
价格
涨跌幅